Recall Z-0675-2019

Tosoh Bioscience Inc · initiated November 30, 2018

Class II Terminated

Class II – products that might cause a temporary health problem or pose a slight threat of a serious nature

Product

ST AIA-PACK Homocysteine (HCY) is designed for IN VITRO DIAGNOSTIC USE ONLY for the quantitative measurement of homocysteine in human serum, heparinized plasma or EDT A plasma on TOSOH AIA System Analyzers. Homocysteine measurements are used in the diagnosis and treatment of hyperhomocysteinemia or homocysteinuria.

Codes / lots: all lots

Reason for recall

—

FDA-determined cause: Device Design

Action taken

On November 30, 2018, Tosoh Bioscience issued Urgent Medical Device Recall notices to customers. Customers are advised to take the following actions: " Do not use the assays identified in notice for those patients who have recently had a fluorescein angiography procedure. For these patients, use an alternative testing method that does not use a fluorescein-based technology. " Inform medical professionals that the Tosoh AIA assays in the notice utilize a fluorescein-based technology and should not be used to test patient samples for patients who have recently undergone fluorescein angiography. " Continue to use the Tosoh AIA assays listed in notice only for patients who have not undergone a fluorescein angiography procedure exam, or on patient samples which have been taken prior to receiving the fluorescein angiography procedure. " Complete & return the Urgent Medical Device Recall Acknowledgement Form within 15-days of receiving the notification. " Maintain a copy of the notification with your laboratory records and forward this information to others who may have received this product. Should you have any questions, please contact Bernadette OConnell at 1(800) 248-6764 or by email at Bernadette.oconnell@tosoh.com. She will be able to answer any questions Monday-Friday from 9 AM to 5 PM (PST).

Details

Recall number
Z-0675-2019
Initiated
November 30, 2018
Terminated
January 14, 2021
Product code
LPS – Urinary Homocystine (Nonquantitative) Test System
Quantity
992 units
Distribution
US Nationwide
Recalling firm
Tosoh Bioscience Inc, Grove City, OH

Official FDA recall record

Other products in the same recall event

RecallProductInitiated
Z-0671-2019 Class IIAIA-PACK B12 (Vitamin B12) is designed for IN VITRO DIAGNOSTIC USE ONLY for the…Potential for fluorescein interference to cause inaccurately elevated results for certain Tosoh AIA assays 11/30/2018Terminated
Z-0672-2019 Class IIAIA-PACK Folate (FOL) is designed for IN VITRO DIAGNOSTIC USE ONLY for the quantitative… 11/30/2018Terminated
Z-0673-2019 Class IIST AIA-PACK FT3 (FT3: Free Triiodothyronine) is designed for IN VITRO DIAGNOSTIC USE… 11/30/2018Terminated
Z-0674-2019 Class IIST AIA-PACK Testosterone (TES) is designed for IN VITRO DIAGNOSTIC USE ONLY for the… 11/30/2018Terminated
Z-0676-2019 Class IIST AIA-PACK ACTH (ACTH: Adrenocorticotropic Hormone) is designed for IN VITRO DIAGNOSTIC… 11/30/2018Terminated